Details for New Drug Application (NDA): 019407
✉ Email this page to a colleague
NDA 019407 describes VISINE L.R., which is a drug marketed by Johnson And Johnson and is included in one NDA. Additional details are available on the VISINE L.R. profile page.
The generic ingredient in VISINE L.R. is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
The generic ingredient in VISINE L.R. is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
Summary for 019407
| Tradename: | VISINE L.R. |
| Applicant: | Johnson And Johnson |
| Ingredient: | oxymetazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019407
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025% | ||||
| Approval Date: | Mar 31, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
